Literature DB >> 25499859

[Gestational trophoblastic disease].

Fabienne Allias1, Pierre-Adrien Bolze2, Lucie Gaillot-Durand3, Mojgan Devouassoux-Shisheboran4.   

Abstract

Gestational trophoblastic disease encompresses a group of interrelated diseases, following a pregnancy after a variable period of time. Hydatiform mole corresponds to premalignant disorders composed of villi with excess of paternal genetic material, with a malignant potential more important for complete mole than partial mole. Gestational trophoblastic neoplasia includes invasive mole, choriocarcinoma, placental site trophoblatic tumor and epithelioid trophoblastic tumor. Their histological diagnosis may be problematic on curettage material and needs to be correlated to serum hCG level and radiological findings. The use of chemotherapy has dramatically improved the prognosis of these lesions. All patients with this rare disease need to be registered in the national service for gestational trophoblastic disease (http://www.mole-chorio.com), which coordinates their management at the national level.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Choriocarcinoma; Choriocarcinome; Gestational trophoblastic disease; Hydatiform mole; Maladies gestationnelles trophoblastiques; Môle hydatiforme

Mesh:

Substances:

Year:  2014        PMID: 25499859     DOI: 10.1016/j.annpat.2014.09.004

Source DB:  PubMed          Journal:  Ann Pathol        ISSN: 0242-6498            Impact factor:   0.407


  3 in total

1.  Pregnancy after oocyte donation in a patient with NLRP7 gene mutations and recurrent molar hydatidiform pregnancies.

Authors:  Claire Cozette; Florence Scheffler; Melyne Lombart; Jerome Massardier; Pierre-Adrien Bolze; Touria Hajri; Francois Golfier; Isabelle Touitou; Cecile Rittore; Jean Gondry; Philippe Merviel; Moncef Benkhalifa; Rosalie Cabry
Journal:  J Assist Reprod Genet       Date:  2020-06-26       Impact factor: 3.412

2.  GDF8 Promotes the Cell Invasiveness in Human Trophoblasts by Upregulating the Expression of Follistatin-Like 3 Through the ALK5-SMAD2/3 Signaling Pathway.

Authors:  Jiamin Xie; Hua Zhu; Hsun-Ming Chang; Christian Klausen; Minyue Dong; Peter C K Leung
Journal:  Front Cell Dev Biol       Date:  2020-10-28

3.  Insulin reverses choriocarcinoma 5- fluorouracil resistance.

Authors:  Ying Shan; Yanyi Li; Hongyu Han; Cui Jiang; Hu Zhang; Jiachang Hu; Huanmei Sun; Jianglong Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.